Oliver Cunningham is the Senior Director of Product Management at Signant Health, providing professional services to pharmaceutical/biotech R&D organizations and driving product innovation in support of Signant Health’s IRT and supply chain technologies. Prior to joining Signant Health in 2017, Oliver spent 14 years at AstraZeneca, holding scientific and supply chain management positions. He is an expert in supply chain management and has held various roles in global planning, clinical supplies and leading early development technical teams. As the Clinical Supply Chain Optimization lead at AstraZeneca, Oliver was responsible for delivering clinical supply chains across all phases of development, including the Fulvestrant and Lynparza programs. Oliver has a Masters in Chemistry with Industrial Chemistry from the University of Liverpool.